Heavy Early Morning Activity On China Biologic Products (CBPO)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified China Biologic Products ( CBPO) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified China Biologic Products as such a stock due to the following factors:

  • CBPO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $21.9 million.
  • CBPO traded 23,096 shares today in the pre-market hours as of 8:58 AM, representing 11.2% of its average daily volume.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CBPO with the Ticky from Trade-Ideas. See the FREE profile for CBPO NOW at Trade-Ideas

More details on CBPO:

China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. CBPO has a PE ratio of 41. Currently there are 2 analysts that rate China Biologic Products a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for China Biologic Products has been 100,400 shares per day over the past 30 days. China Biologic has a market cap of $2.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.48 and a short float of 0.4% with 0.29 days to cover. Shares are up 76.4% year-to-date as of the close of trading on Monday.

If you liked this article you might like

Chinese Plasma Maker China Biologic a Solid Addition for a Portfolio

Today's Perilous Reversal Stock: China Biologic Products (CBPO)

Strong On High Relative Volume: China Biologic Products (CBPO)

Insider Trading Alert - UUUU, ZAYO And CBPO Traded By Insiders

China Biologic Products (CBPO) Highlighted as Today's Perilous Reversal Stock